Testing effectiveness (Phase 2)UnknownNCT05273541
What this trial is testing
Safety and Immunogenicity of Prime-boost Vaccination of SARS-CoV-2 in Patients With Cancer
Who this might be right for
Patients With CancerVaccine ReactionCOVID-19
Beijing 302 Hospital 100